Dyadic reports 2023 full year results and recent company progress

Jupiter, fla., march 28, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness, today announced its financial results for the year end 2023 and highlighted recent company progress.
DYAI Ratings Summary
DYAI Quant Ranking